Regal Assets Analytics

SanaCurrents on PDFUA decision for Travere’s (TVTX) Sparsentan to treat IgAN

By |2022-05-22T16:46:04-04:00May 22nd, 2022|Tags: |

Travere Therapeutics, Inc. (NASDAQ:TVTX) Probability Sentiment SUMMARY Travere Therapeutics’ (NASDAQ:TVTX) received a PDUFA decision date [...]

SanaCurrents Speculative on Adicet’s (ACET) upcoming gamma-delta cancer data at the June ASCO meeting

By |2022-05-18T13:37:22-04:00May 14th, 2022|Tags: |

Adicet Bio, Inc. (NASDAQ:ACET) Probability Sentiment SUMMARY While first-generation, autologous chimeric antigen receptor (CAR) T [...]

SanaCurrents on Insmed’s (INSM) entry in pulmonary arterial hypertension (PAH)

By |2022-05-18T13:37:33-04:00May 7th, 2022|Tags: |

Insmed, Inc. (NASDAQ:INSM) Probability Sentiment SUMMARY Pulmonary arterial hypertension (PAH) comprises a group of severe [...]

SanaCurrents Pivotal on Humacyte’s (HUMA) regenerative blood vessels

By |2022-05-03T12:23:54-04:00April 30th, 2022|Tags: |

Humacyte, Inc. (NASDAQ:HUMA) Probability Sentiment SUMMARY Regenerative medicine, the therapeutic research devoted to the regrowth [...]

SanaCurrents capturing gain after Spectrum’s (SPPI) PDUFA catalyst up 92%; closing out BioXcel (BTAI)

By |2022-04-26T08:59:56-04:00April 5th, 2022|Tags: , |

Since SanaCurrents issued a report on Spectrum Pharmaceuticals’ (SPPI) cancer drug poziotinib on February 25, the company’s stock price has climbed 92%, closing [...]

SanaCurrents on Relmada’s (RLMD) push for REL-1017 to treat depression

By |2022-04-04T08:18:31-04:00April 2nd, 2022|Tags: |

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Probability Sentiment SUMMARY While current anti-depressants provide some relief, most physicians [...]

Go to Top